We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

16 hedge funds and large institutions have $11.7M invested in Achieve Life Sciences in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

192% more capital invested

Capital invested by funds: $3.99M → $11.7M (+$7.67M)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

2.76% more ownership

Funds ownership: 13.62% → 16.38% (+2.8%)

0% more funds holding

Funds holding: 16 → 16 (0)

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
2
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$3.19M
2
SC
Shay Capital
New York
+$1.6M
3
Morgan Stanley
Morgan Stanley
New York
+$1.04M
4
LPL Financial
LPL Financial
California
+$628K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$348K

Top Sellers

1
SC
Skylands Capital
Wisconsin
-$223K
2
HR
Hayden Royal
North Carolina
-$181K
3
Millennium Management
Millennium Management
New York
-$162K
4
Goldman Sachs
Goldman Sachs
New York
-$88K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$85K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.43M +$3.19M +268,741 +988%
IC
2
Ikarian Capital
Texas
$3.29M – – –
SC
3
Shay Capital
New York
$1.56M +$1.6M +135,000 New
Morgan Stanley
4
Morgan Stanley
New York
$1.01M +$1.04M +87,545 +8,754,500%
LPL Financial
5
LPL Financial
California
$613K +$628K +52,900 New
PCM
6
Perkins Capital Management
Minnesota
$470K – – –
BFM
7
Boothbay Fund Management
New York
$387K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$339K +$348K +29,290 New
Renaissance Technologies
9
Renaissance Technologies
New York
$255K +$262K +22,061 New
Citadel Advisors
10
Citadel Advisors
Florida
$144K +$148K +12,456 New
TPA
11
Trivium Point Advisory
Connecticut
$129K +$132K +11,100 New
TRCT
12
Tower Research Capital (TRC)
New York
$16K +$11.8K +996 +260%
BlackRock
13
BlackRock
New York
$4K -$439 -37 -9%
NFSG
14
Newbridge Financial Services Group
Florida
$4K +$3.66K +308 New
Wells Fargo
15
Wells Fargo
California
$3K -$2.62K -221 -41%
GAM
16
Gemmer Asset Management
California
$3K +$3.56K +300 New
SC
17
Skylands Capital
Wisconsin
– -$223K -27,500 Closed
HR
18
Hayden Royal
North Carolina
– -$181K -22,340 Closed
Millennium Management
19
Millennium Management
New York
– -$162K -19,971 Closed
Goldman Sachs
20
Goldman Sachs
New York
– -$88K -10,816 Closed
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
– -$85K -10,510 Closed
GCP
22
GSA Capital Partners
United Kingdom
– -$82K -10,129 Closed
UBS Group
23
UBS Group
Switzerland
– -$41K -5,064 Closed

ACHV Hedge Fund Activity: Q1 2021 in Review

16 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q1 2021, worth a combined $11.7M — up 192% from $3.99M a quarter earlier.

Fund positioning in ACHV was balanced in Q1 2021: 8 funds opened new positions, 8 closed out, 3 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $3.19M. The largest seller was Skylands Capital, exiting entirely with an estimated $223K sold.

  • 16 institutional investors held Achieve Life Sciences (ACHV) as of Q1 2021, unchanged from Q4 2020.
  • Funds reported $11.7M of Achieve Life Sciences stock for Q1 2021, up 192% quarter-over-quarter.
  • 8 funds opened new Achieve Life Sciences positions in Q1 2021 and 8 closed out, a net change of 0 holders.
  • The largest Achieve Life Sciences buyer in Q1 2021 was Vanguard Group, an estimated $3.19M added.
  • The largest Achieve Life Sciences seller in Q1 2021 was Skylands Capital, an estimated $223K sold.

Based on aggregated 13F filings for Q1 2021.